PILOTING A PATH FOR DIGITAL INNOVATION
( after fielding interest from over 100 companies ). The FDA arrived at the final nine after considering “ company size , demonstrated record of quality and organisational excellence , clinical focus area and the risk profile of the product ”. The selection process identified companies representing different perspectives and unique approaches to digital
health technology development . “ The number of applicants speaks to the significant impact this approach could have on facilitating timely advancement of software that has the potential to benefit health ,” says Bakul Patel , associate director for digital health in the FDA ’ s Centre for Devices and Radiological Health .
THE FIRMS THAT MADE THE CUT ARE :
19